– Results from the completed Collaborative Health Research Projects study with McMaster University presented at the American Thoracic Society International Conference – – Data. | May 23, 2023
? 2022 marks Ceapro's best performance in Company history with record sales of $18,800,000 compared to $17,200,000 for 2021, representing a 10% increase year over year ? Net profit after tax of $4,400,000 for the full year of 2022 compared to.
Oral presentation to highlight unique results from pre-clinical studies demonstrating potential of Ceapro’s yeast beta glucan to reprogram macrophages involved…
/PRNewswire/ Aria Pharmaceuticals, a pharmaceutical company focused on bringing first-in-class small molecules to market, today announced that its lead.
Algernon Pharmaceuticals Inc says global expert on IPF describes results from Phase 2a study on Ifenprodil as excellent proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.